NARS2

Chr 11AR

asparaginyl-tRNA synthetase 2, mitochondrial

Also known as: DFNB94, SLM5, asnRS

This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of asparagine to tRNA molecules. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 24 (COXPD24). [provided by RefSeq, Mar 2015]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.862 OMIM phenotypes
Clinical SummaryNARS2
🧬
Gene-Disease Validity (ClinGen)
Leigh syndrome · ARLimited

Limited evidence — not for standalone diagnostic reporting

3 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 156 VUS of 429 total submissions
📖
GeneReview available — NARS2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.86LOEUF
pLI 0.000
Z-score 2.12
OE 0.57 (0.380.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.76Z-score
OE missense 1.13 (1.031.25)
292 obs / 257.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.57 (0.380.86)
00.351.4
Missense OE?1.13 (1.031.25)
00.61.4
Synonymous OE?1.14
01.21.6
LoF obs/exp: 16 / 28.2Missense obs/exp: 292 / 257.7Syn Z: -1.04
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveNARS2-related oxidative phosphorylation deficiencyLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.76top 25%
GOF
0.5759th %ile
LOF
0.2483th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

429 submitted variants in ClinVar

Classification Summary

Pathogenic21
Likely Pathogenic16
VUS156
Likely Benign149
Benign51
Conflicting23
21
Pathogenic
16
Likely Pathogenic
156
VUS
149
Likely Benign
51
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
4
4
0
21
Likely Pathogenic
9
6
1
0
16
VUS
6
140
9
1
156
Likely Benign
0
4
88
57
149
Benign
0
4
43
4
51
Conflicting
23
Total2815814562416

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

10 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap NARS2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NARS2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →